UK markets close in 2 hours 10 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
140.55-1.10 (-0.78%)
At close: 04:00PM EDT
140.50 -0.05 (-0.04%)
Pre-market: 08:28AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,982,000
1,887,100
1,488,700
1,133,500
1,045,900
-
Cost of revenue
38,700
39,700
23,200
14,300
10,100
-
Gross profit
1,943,300
1,847,400
1,465,500
1,119,200
1,035,800
-
Operating expenses
Research development
584,900
565,000
463,800
328,100
275,000
-
Selling general and administrative
888,000
887,600
752,700
583,300
433,300
-
Total operating expenses
1,472,900
1,452,600
1,216,500
911,400
708,300
-
Operating income or loss
470,400
394,800
249,000
207,800
327,500
-
Interest expense
4,600
4,600
7,100
25,800
32,800
-
Total other income/expenses net
4,100
-58,100
-28,000
-80,600
-188,000
-
Income before tax
469,900
332,100
213,900
101,400
106,700
-
Income tax expense
100,200
82,400
59,400
11,800
-300,600
-
Income from continuing operations
369,700
249,700
154,500
89,600
407,300
-
Net income
369,700
249,700
154,500
89,600
407,300
-
Net income available to common shareholders
369,700
249,700
154,500
89,600
407,300
-
Basic EPS
1.97
-
1.61
0.95
4.38
0.40
Diluted EPS
1.90
-
1.56
0.92
4.16
0.39
Basic average shares
97,225
-
95,800
94,600
93,100
91,600
Diluted average shares
100,625
-
98,900
97,900
97,800
95,700